Muramyl dipeptide induces Th17 polarization through activation of endothelial cells

Journal of Immunology

Volumn 186, Issue 6, 2011, Pages 3356-3363

  Manni, Michela ^a   Ding, Wanhong ^a   Stohl, Lori L ^a   Granstein, Richard D ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 22; INTERLEUKIN 4; INTERLEUKIN 6; MURAMYL DIPEPTIDE; RETINOID RELATED ORPHAN RECEPTOR GAMMA;

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; FEMALE; IN VITRO STUDY; LANGERHANS CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH17 CELL; TH2 CELL;

ACETYLMURAMYL-ALANYL-ISOGLUTAMINE; ANIMALS; CELL LINE; CELL LINE, TRANSFORMED; CELL POLARITY; COCULTURE TECHNIQUES; ENDOTHELIAL CELLS; FEMALE; INTERFERON-GAMMA; INTERLEUKIN-4; INTERLEUKIN-6; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; SKIN; TH1 CELLS; TH17 CELLS; TH2 CELLS; UP-REGULATION;

EID: 79953173587     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1000847     Document Type: Article

References (42)

1. Danese, S., E. Dejana, and C. Fiocchi. 2007. Immune regulation by microvascular endothelial cells: directing innate and adaptive immunity, coagulation, and inflammation. J. Immunol. 178: 6017-6022. (Pubitemid 46717378)
2. Kanneganti, T. D., M. Lamkanfi, and G. Núñez. 2007. Intracellular NOD-like receptors in host defense and disease. Immunity 27: 549-559. (Pubitemid 47615512)
3. Kambe, N., R. Nishikomori, and N. Kanazawa. 2005. The cytosolic pattern-recognition receptor Nod2 and inflammatory granulomatous disorders. J. Dermatol. Sci. 39: 71-80.
4. Strober, W., A. Kitani, I. Fuss, N. Asano, and T. Watanabe. 2008. The molecular basis of NOD2 susceptibility mutations in Crohn's disease. Mucosal Immunol. 1 (Suppl 1): S5-S9.
5. Bettelli, E., Y. Carrier, W. Gao, T. Korn, T. B. Strom, M. Oukka, H. L. Weiner, and V. K. Kuchroo. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235-238.
6. Langrish, C. L., Y. Chen, W. M. Blumenschein, J. Mattson, B. Basham, J. D. Sedgwick, T. McClanahan, R. A. Kastelein, and D. J. Cua. 2005. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201: 233-240.
7. O'Garra, A., B. Stockinger, and M. Veldhoen. 2008. Differentiation of human T (H)-17 cells does require TGF-beta! Nat. Immunol. 9: 588-590. (Pubitemid 351712629)
8. Duhen, T., R. Geiger, D. Jarrossay, A. Lanzavecchia, and F. Sallusto. 2009. Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat. Immunol. 10: 857-863.
9. Trifari, S., C. D. Kaplan, E. H. Tran, N. K. Crellin, and H. Spits. 2009. Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells. Nat. Immunol. 10: 864-871.
10. Davey, M. P., T. M. Martin, S. R. Planck, J. Lee, D. Zamora, and J. T. Rosenbaum. 2006. Human endothelial cells express NOD2/CARD15 and increase IL-6 secretion in response to muramyl dipeptide. Microvasc. Res. 71: 103-107.
11. van Beelen, A. J., Z. Zelinkova, E. W. Taanman-Kueter, F. J. Muller, D. W. Hommes, S. A. Zaat, M. L. Kapsenberg, and E. C. de Jong. 2007. Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells. Immunity 27: 660-669. (Pubitemid 47615504)
12. Su, X., J. Ye, E. C. Hsueh, Y. Zhang, D. F. Hoft, and G. Peng. 2010. Tumor microenvironments direct the recruitment and expansion of human Th17 cells. J. Immunol. 184: 1630-1641.
13. Oukka, M. 2008. Th17 cells in immunity and autoimmunity. Ann. Rheum. Dis. 67(Suppl 3): iii26-iii29.
14. Mitchell, P., B. Afzali, G. Lombardi, and R. I. Lechler. 2009. The T helper 17- regulatory T cell axis in transplant rejection and tolerance. Curr. Opin. Organ Transplant. 14: 326-331.
15. Kappel, L. W., G. L. Goldberg, C. G. King, D. Y. Suh, O. M. Smith, C. Ligh, A. M. Holland, J. Grubin, N. M. Mark, C. Liu, et al. 2009. IL-17 contributes to CD4-mediated graft-versus-host disease. Blood 113: 945-952.
16. Piskin, G., R. M. Sylva-Steenland, J. D. Bos, and M. B. Teunissen. 2006. In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin. J. Immunol. 176: 1908-1915.
17. Lowes, M. A., T. Kikuchi, J. Fuentes-Duculan, I. Cardinale, L. C. Zaba, A. S. Haider, E. P. Bowman, and J. G. Krueger. 2008. Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J. Invest. Dermatol. 128: 1207-1211.
18. Neuner, P., A. Urbanski, F. Trautinger, A. Möller, R. Kirnbauer, A. Kapp, E. Schöpf, T. Schwarz, and T. A. Luger. 1991. Increased IL-6 production by monocytes and keratinocytes in patients with psoriasis. J. Invest. Dermatol. 97: 27-33.
19. Grossman, R. M., J. Krueger, D. Yourish, A. Granelli-Piperno, D. P. Murphy, L. T. May, T. S. Kupper, P. B. Sehgal, and A. B. Gottlieb. 1989. Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. Proc. Natl. Acad. Sci. USA 86: 6367-6371.
20. Sato, K., A. Suematsu, K. Okamoto, A. Yamaguchi, Y. Morishita, Y. Kadono, S. Tanaka, T. Kodama, S. Akira, Y. Iwakura, et al. 2006. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J. Exp. Med. 203: 2673-2682.
21. Lock, C., G. Hermans, R. Pedotti, A. Brendolan, E. Schadt, H. Garren, A. Langer-Gould, S. Strober, B. Cannella, J. Allard, et al. 2002. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat. Med. 8: 500-508.
22. Boniface, K., E. Guignouard, N. Pedretti, M. Garcia, A. Delwail, F. X. Bernard, F. Nau, G. Guillet, G. Dagregorio, H. Yssel, et al. 2007. A role for T cell-derived interleukin 22 in psoriatic skin inflammation. Clin. Exp. Immunol. 150: 407-415.
23. Nograles, K. E., L. C. Zaba, A. Shemer, J. Fuentes-Duculan, I. Cardinale, T. Kikuchi, M. Ramon, R. Bergman, J. G. Krueger, and E. Guttman-Yassky. 2009. IL-22-producing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells. J. Allergy Clin. Immunol. 123: 1244-1252.e1242.
24. Romani, N., S. Ebner, C. H. Tripp, V. Flacher, F. Koch, and P. Stoitzner. 2006. Epidermal Langerhans cells - changing views on their function in vivo. Immunol. Lett. 106: 119-125.
25. Romani, N., S. Holzmann, C. H. Tripp, F. Koch, and P. Stoitzner. 2003. Langerhans cells - dendritic cells of the epidermis. APMIS 111: 725-740. (Pubitemid 37130020)
26. Kaplan, D. H., A. Kissenpfennig, and B. E. Clausen. 2008. Insights into Langerhans cell function from Langerhans cell ablation models. Eur. J. Immunol. 38: 2369-2376.
27. Montesano, R., M. S. Pepper, U. Möhle-Steinlein, W. Risau, E. F. Wagner, and L. Orci. 1990. Increased proteolytic activity is responsible for the aberrant morphogenetic behavior of endothelial cells expressing the middle T oncogene. Cell 62: 435-445.
28. Azuma, M., T. Tamatani, K. Fukui, T. Bando, and M. Sato. 1994. Enhanced proteolytic activity is responsible for the aberrant morphogenetic development of SV40-immortalized normal human salivary gland cells grown on basement membrane components. Lab. Invest. 70: 217-227.
29. Sikorski, E. E., R. Hallmann, E. L. Berg, and E. C. Butcher. 1993. The Peyer's patch high endothelial receptor for lymphocytes, the mucosal vascular addressin, is induced on a murine endothelial cell line by tumor necrosis factor-alpha and IL-1. J. Immunol. 151: 5239-5250.
30. Lichti, U., J. Anders, and S. H. Yuspa. 2008. Isolation and short-term culture of primary keratinocytes, hair follicle populations and dermal cells from newborn mice and keratinocytes from adult mice for in vitro analysis and for grafting to immunodeficient mice. Nat. Protoc. 3: 799-810.
31. Granstein, R. D., M. Askari, D. Whitaker, and G. F. Murphy. 1987. Epidermal cells in activation of suppressor lymphocytes: further characterization. J. Immunol. 138: 4055-4062.
32. Schuler, G., and R. M. Steinman. 1985. Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro. J. Exp. Med. 161: 526-546.
33. Julius, M. H., E. Simpson, and L. A. Herzenberg. 1973. A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur. J. Immunol. 3: 645-649.
34. Pfaffl, M. W., G. W. Horgan, and L. Dempfle. 2002. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 30: e36.
35. Sallusto, F., and A. Lanzavecchia. 2009. Heterogeneity of CD4+ memory T cells: functional modules for tailored immunity. Eur. J. Immunol. 39: 2076-2082.
36. Benwell, R. K., and D. R. Lee. 2010. Essential and synergistic roles of IL1 and IL6 in human Th17 differentiation directed by TLR ligand-activated dendritic cells. Clin. Immunol. 134: 178-187.
37. Korn, T., M. Mitsdoerffer, A. L. Croxford, A. Awasthi, V. A. Dardalhon, G. Galileos, P. Vollmar, G. L. Stritesky, M. H. Kaplan, A. Waisman, et al. 2008. IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3+ regulatory T cells. Proc. Natl. Acad. Sci. USA 105: 18460-18465.
38. Eyerich, S., K. Eyerich, D. Pennino, T. Carbone, F. Nasorri, S. Pallotta, F. Cianfarani, T. Odorisio, C. Traidl-Hoffmann, H. Behrendt, et al. 2009. Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J. Clin. Invest. 119: 3573-3585.
39. Mathers, A. R., B. M. Janelsins, J. P. Rubin, O. A. Tkacheva, W. J. Shufesky, S. C.Watkins, A. E. Morelli, and A. T. Larregina. 2009. Differential capability of human cutaneous dendritic cell subsets to initiate Th17 responses. J. Immunol. 182: 921-933.
40. Krahenbuhl, J. L., and R. C. Humphres. 1983. Effects of treatment with muramyl dipeptide on resistance to Mycobacterium leprae and Mycobacterium marinum infection in mice. Immunopharmacology 5: 329-339.
41. Sridevi, K., N. Khanna, V. Chattree, P. C. Pal, W. Haq, and D. N. Rao. 2003. Reversal of T cell anergy in leprosy patients: in vitro presentation with Mycobacterium leprae antigens using murabutide and Trat peptide in liposomal delivery. Int. Immunopharmacol. 3: 1589-1600.
42. Bhandarkar, S. S., C. Cohen, M. Kuruvila, T. H. Rea, J. B. Mackelfresh, D. J. Lee, R. L. Modlin, and J. L. Arbiser. 2007. Angiogenesis in cutaneous lesions of leprosy: implications for treatment. Arch. Dermatol. 143: 1527-1529.